Literature DB >> 6838175

Oligoclonal IgG bands in cerebrospinal fluid in various neurological diseases.

A B Chu, J L Sever, D L Madden, M Iivanainen, M Leon, W Wallen, B R Brooks, Y J Lee, S Houff.   

Abstract

We studied the frequency of oligoclonal immunoglobulin G bands in the cerebrospinal fluid (CSF) of patients with various neurological diseases. We used a micromethod employing sodium dodecyl sulfate polyacrylamide gel electrophoresis that required only 50 microliters of unconcentrated CSF. Oligoclonal bands were detected in the CSF of 95% of the patients with multiple sclerosis, 90% with subacute sclerosing panencephalitis, and 100% with herpes simplex encephalitis, but less frequently in other central nervous system infections. No oligoclonal bands were detected in the CSF of patients with Parkinson, Huntington, Creutzfeldt-Jakob, or herniated disc diseases. Bands were detected in some patients with Alzheimer disease, cerebrovascular accident, idiopathic vertigo, idiopathic seizures, amyotrophic lateral sclerosis, polyneuropathy, and central nervous system glioma. Patients with other conditions infrequently had positive bands. The determination of oligoclonal bands is a useful aid in the diagnosis of multiple sclerosis, subacute sclerosing panencephalitis, and herpes simplex encephalitis. The presence of oligoclonal bands indicates an immunological response but is not diagnostic for a particular condition.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6838175     DOI: 10.1002/ana.410130410

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  21 in total

Review 1.  Immunology of amyotrophic lateral sclerosis.

Authors:  N R Cashman; M E Gurney; J P Antel
Journal:  Springer Semin Immunopathol       Date:  1985

Review 2.  Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice.

Authors:  Andrew J Solomon; Robert T Naismith; Anne H Cross
Journal:  Neurology       Date:  2018-10-31       Impact factor: 9.910

3.  Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?

Authors:  Nadja Borisow; Thomas Meyer; Friedemann Paul
Journal:  BMJ Case Rep       Date:  2013-01-23

4.  Bronchiectasis with ulcerative colitis and myelopathy.

Authors:  W R Gibb; D P Dhillon; K J Zilkha; P J Cole
Journal:  Thorax       Date:  1987-02       Impact factor: 9.139

Review 5.  The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature.

Authors:  S Jarius; P Eichhorn; D Franciotta; H F Petereit; G Akman-Demir; M Wick; B Wildemann
Journal:  J Neurol       Date:  2016-12-22       Impact factor: 4.849

Review 6.  The clinical use of cerebrospinal fluid studies in demyelinating neurological diseases.

Authors:  M G Harrington; P G Kennedy
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

7.  Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer's disease.

Authors:  H M Chapel; M M Esiri; G K Wilcock
Journal:  J Clin Pathol       Date:  1984-06       Impact factor: 3.411

8.  Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders.

Authors:  O G Segurado; H Krüger; H G Mertens
Journal:  J Neurol       Date:  1986-08       Impact factor: 4.849

9.  Detection of IgG oligoclonal bands in unconcentrated CSF by means of agarose isoelectric focusing, double immunofixation peroxidase staining and avidin-biotin amplification.

Authors:  P Gallo; F Bracco; L Battistin; B Tavolato
Journal:  Ital J Neurol Sci       Date:  1985-09

10.  Magnetic resonance imaging in multiple sclerosis: diagnostic value and clinical correlations.

Authors:  C Milanese; M Savoiardo; L La Mantia; A Campi; A Visciani; A Salmaggi; L Tajoli Malesani
Journal:  Ital J Neurol Sci       Date:  1988-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.